Proteogenix Confirms Series B

Proteogenix Inc., a Portland, Ore.-based developer of proteomic and genomic tests to detect and monitor fetal disorders, confirmed that it has raised $20 million in Series B funding. PE Week Wire first reported the news last week. New Leaf Ventures and TPG Ventures co-led the deal, and were joined by return backer Burrill & Co.